Skip to main content

NYSE:INSP - Inspire Medical Systems Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $177.70
  • Forecasted Upside: -8.68 %
  • Number of Analysts: 9
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$194.60
▲ +3 (1.57%)
1 month | 3 months | 12 months
Get New Inspire Medical Systems Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for INSP and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for INSP

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$177.70
▼ -8.68% Downside Potential
This price target is based on 9 analysts offering 12 month price targets for Inspire Medical Systems in the last 3 months. The average price target is $177.70, with a high forecast of $275.00 and a low forecast of $50.00. The average price target represents a -8.68% upside from the last price of $194.60.

Buy

The current consensus among 9 investment analysts is to buy stock in Inspire Medical Systems. This rating has held steady since February 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/15/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
2/13/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
5/13/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 4 hold ratings
  • 0 sell ratings
8/11/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 0 sell ratings
11/9/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 0 sell ratings
2/7/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/8/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
5/8/2021

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/5/2021Lake Street CapitalBoost Price TargetBuy$250.00 ➝ $260.00High
i
5/5/2021Piper SandlerBoost Price TargetPositive ➝ Overweight$252.00 ➝ $255.00High
i
4/25/2021Robert W. BairdReiterated RatingBuyHigh
i
3/2/2021SVB LeerinkBoost Price TargetOutperform$225.00 ➝ $275.00Medium
i
3/2/2021Piper SandlerBoost Price TargetOverweight$210.00 ➝ $252.00Medium
i
2/24/2021Piper SandlerBoost Price TargetOverweight$210.00 ➝ $252.00Medium
i
2/24/2021Lake Street CapitalBoost Price TargetBuy$215.00 ➝ $250.00Low
i
2/24/2021SVB LeerinkBoost Price TargetOutperform$225.00 ➝ $275.00High
i
1/7/2021Lake Street CapitalBoost Price TargetBuy$150.00 ➝ $215.00Low
i
1/4/2021Bank of AmericaDowngradeBuy ➝ NeutralN/A
i
Rating by Bob Hopkins at Bank of America Co.
12/15/2020The Goldman Sachs GroupDowngradeBuy ➝ Neutral$162.00 ➝ $209.00Low
i
12/3/2020Piper SandlerBoost Price TargetOverweight$147.00 ➝ $210.00Medium
i
11/3/2020Wells Fargo & CompanyBoost Price TargetOverweight$135.00 ➝ $140.00High
i
11/3/2020SVB LeerinkBoost Price TargetOutperform$150.00 ➝ $170.00High
i
11/3/2020Robert W. BairdBoost Price TargetOutperform$130.00 ➝ $160.00High
i
11/3/2020Bank of AmericaUpgradeNeutral ➝ Buy$125.00 ➝ $155.00High
i
Rating by Bob Hopkins at Bank of America Co.
11/3/2020Piper SandlerBoost Price TargetOverweight$137.00 ➝ $147.00High
i
11/3/2020OppenheimerUpgradeUnderperform ➝ Market PerformHigh
i
Rating by Suraj Kalia at Oppenheimer Holdings Inc.
9/22/2020JPMorgan Chase & Co.Initiated CoverageOverweight$148.00High
i
9/18/2020Piper SandlerBoost Price TargetPositive ➝ Overweight$116.00 ➝ $137.00High
i
Rating by Adam Maeder at Piper Sandler
9/10/2020Wells Fargo & CompanyBoost Price TargetOverweight$125.00 ➝ $135.00Medium
i
9/9/2020SVB LeerinkBoost Price TargetPositive ➝ Outperform$120.00 ➝ $150.00High
i
9/1/2020Robert W. BairdInitiated CoverageOutperform$130.00Low
i
8/21/2020Stifel NicolausBoost Price Target$110.00 ➝ $125.00Low
i
8/6/2020Wells Fargo & CompanyBoost Price TargetPositive ➝ Overweight$115.00 ➝ $125.00Medium
i
8/6/2020Bank of AmericaDowngradeBuy ➝ Neutral$115.00High
i
8/5/2020Piper SandlerBoost Price Target$98.00 ➝ $111.00Low
i
Rating by Adam Maeder at Piper Sandler
8/5/2020SVB LeerinkBoost Price TargetOutperform$110.00 ➝ $120.00High
i
8/5/2020Lake Street CapitalBoost Price TargetBuy$100.00 ➝ $130.00High
i
Rating by Frank Takkinen at Lake Street Capital
8/5/2020OppenheimerReiterated RatingSell$42.00 ➝ $50.00High
i
Rating by Suraj Kalia at Oppenheimer Holdings Inc.
7/15/2020The Goldman Sachs GroupInitiated CoverageBuy$148.00High
i
6/29/2020SVB LeerinkBoost Price TargetOutperform$85.00 ➝ $110.00Low
i
6/18/2020Piper SandlerBoost Price TargetOverweight$81.00 ➝ $98.00Medium
i
Rating by Adam Maeder at Piper Sandler
5/26/2020Wells Fargo & CompanyBoost Price TargetOverweight$81.00 ➝ $95.00High
i
5/18/2020Lake Street CapitalInitiated CoverageBuy$90.00High
i
5/6/2020GuggenheimBoost Price TargetBuy$80.00 ➝ $90.00High
i
5/6/2020OppenheimerInitiated CoverageSell$42.00High
i
Rating by Suraj Kalia at Oppenheimer Holdings Inc.
4/28/2020Bank of AmericaUpgradeNeutral ➝ Buy$90.00High
i
4/19/2020Piper SandlerInitiated CoverageOverweight$74.00Medium
i
Rating by Adam Maeder at Piper Sandler
4/15/2020Stifel NicolausBoost Price TargetBuy$88.00 ➝ $95.00Low
i
4/9/2020Piper SandlerInitiated CoverageOverweight$74.00High
i
4/2/2020OppenheimerLower Price Target$50.00 ➝ $42.00Medium
i
Rating by Suraj Kalia at Oppenheimer Holdings Inc.
2/26/2020Bank of AmericaBoost Price TargetNeutral$75.00 ➝ $85.00High
i
2/26/2020Stifel NicolausBoost Price TargetBuy$82.00 ➝ $88.00High
i
2/26/2020SVB LeerinkBoost Price TargetOutperform$75.00 ➝ $97.00High
i
2/26/2020Wells Fargo & CompanyBoost Price TargetOverweight$90.00 ➝ $93.00High
i
1/27/2020OppenheimerInitiated CoverageUnderperform$50.00High
i
1/16/2020Wells Fargo & CompanyBoost Price TargetOverweight$70.00 ➝ $90.00High
i
11/6/2019Berenberg BankUpgradeSell ➝ Hold$46.00 ➝ $51.00High
i
9/27/2019Dougherty & CoSet Price TargetBuy$78.00High
i
Rating by Kyle Bauser at Dougherty & Co
7/8/2019Bank of AmericaReiterated RatingPositive ➝ Neutral$65.00 ➝ $75.00Low
i
2/5/2019Dougherty & CoInitiated CoverageBuy ➝ Buy$64.00High
i
11/28/2018Berenberg BankInitiated CoverageSell ➝ Sell$31.00High
i
10/29/2018SVB LeerinkInitiated CoverageOutperform ➝ Outperform$57.00High
i
Rating by R. Newitter at SVB Leerink LLC
5/29/2018Wells Fargo & CompanyInitiated CoverageOutperform$38.00High
i
5/29/2018Bank of AmericaInitiated CoverageNeutral$36.00High
i
5/29/2018GuggenheimInitiated CoverageBuy$40.00High
i
5/29/2018The Goldman Sachs GroupInitiated CoverageNeutral$25.00High
i
5/29/2018Stifel NicolausInitiated CoverageBuy$42.00High
i
(Data available from 5/9/2016 forward)
Inspire Medical Systems logo
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Read More

Today's Range

Now: $194.60
$192.37
$199.67

50 Day Range

MA: $216.01
$188.72
$242.23

52 Week Range

Now: $194.60
$65.71
$252.25

Volume

266,491 shs

Average Volume

226,945 shs

Market Capitalization

$5.30 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.71

Frequently Asked Questions

What sell-side analysts currently cover shares of Inspire Medical Systems?

The following Wall Street sell-side analysts have issued research reports on Inspire Medical Systems in the last twelve months: Bank of America Co., JPMorgan Chase & Co., Lake Street Capital, Oppenheimer Holdings Inc., Piper Sandler, Robert W. Baird, Stifel Nicolaus, SVB Leerink LLC, The Goldman Sachs Group, Inc., Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for INSP.

What is the current price target for Inspire Medical Systems?

10 Wall Street analysts have set twelve-month price targets for Inspire Medical Systems in the last year. Their average twelve-month price target is $177.70, suggesting a possible downside of 8.7%. SVB Leerink LLC has the highest price target set, predicting INSP will reach $275.00 in the next twelve months. Oppenheimer Holdings Inc. has the lowest price target set, forecasting a price of $50.00 for Inspire Medical Systems in the next year.
View the latest price targets for INSP.

What is the current consensus analyst rating for Inspire Medical Systems?

Inspire Medical Systems currently has 3 hold ratings and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe INSP will outperform the market and that investors should add to their positions of Inspire Medical Systems.
View the latest ratings for INSP.

What other companies compete with Inspire Medical Systems?

How do I contact Inspire Medical Systems' investor relations team?

Inspire Medical Systems' physical mailing address is 5500 WAYZATA BLVD SUITE 1600, GOLDEN VALLEY MN, 55416. The company's listed phone number is 844-672-4357 and its investor relations email address is [email protected] The official website for Inspire Medical Systems is www.inspiresleep.com.